Controlled Fluid Resuscitation in Sepsis
NCT03214913 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 550
Last updated 2017-07-12
Summary
To evaluate two different strategy of fluid resuscitation in sepsis patients
Conditions
Interventions
- OTHER
-
Early Goal Directed Therapy
EGDT therapy :30ml/kg in the first bolus to have a CVP 8-12 mmHg and MAP 65-85 mm Hg,and urine output ≥0.5 ml/kg/h, ScvO2 ≤70%;If not, use noradrenine,red blood cell transfusion if necessary.
- OTHER
-
Ruijin Strategy
Ruijin Strategy:10\~5ml/kg/h,crystalloid vs colloid 2:1 resuscitation;using noradrenaline at the same time;red blood cell transfusion if necessary. target: fulfillment of two or more of four criteria:1. HR \<120 beats/min, 2.MAP 65-85 mm Hg, 3. urine output ≥1 ml/kg /h 4. HCT 25%\~35%.
Sponsors & Collaborators
-
RenJi Hospital
collaborator OTHER -
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
collaborator OTHER -
Ruijin Hospital
lead OTHER
Principal Investigators
-
Zhen Er Chen · Shanghai Jiao Tong University School of Medicine
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 8 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-01-01
- Primary Completion
- 2020-12-31
- Completion
- 2021-06-30
More Related Trials
-
Resuscitation Strategies in Septic Shock
NCT02150512 ·Status: UNKNOWN ·Phase: NA
-
Ultrasound Optimization of Initial Fluid Challenge in Sepsis
NCT04028102 ·Status: UNKNOWN
-
Preemptive Resuscitation for Eradication of Septic Shock
NCT01449721 ·Status: COMPLETED ·Phase: NA
-
Fluid Intolerance Signals as Safety Limits to Prevent Fluid-induced Harm During Septic Shock Resuscitation
NCT06568744 ·Status: RECRUITING ·Phase: NA
-
Temperature Gradients for Sepsis Severity and Fluid Resuscitation
NCT04068298 ·Status: UNKNOWN
-
The Effect of CUGP Fluid Management in Patients With Sepsis or Septic Shock
NCT06879249 ·Status: COMPLETED ·Phase: NA
-
Use of Dobutamine in Patients With Sepsis and Maintained Hypoperfusion After Initial Volemic Resuscitation.
NCT05953142 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Endotoxin Activity Assay and Microcirculation in Severe Sepsis
NCT02452138 ·Status: UNKNOWN
-
The Application of SERS and Metabolomics in Sepsis
NCT02213237 ·Status: UNKNOWN
-
Repository for Sepsis and Postresuscitation Samples
NCT01670383 ·Status: RECRUITING
-
Protocolised Early De-Resuscitation in Septic Shock (REDUCE)
NCT04931485 ·Status: COMPLETED ·Phase: NA
-
Early Lactate Clearance Rate in Sepsis
NCT04192279 ·Status: UNKNOWN
-
Evaluation of Fluid Resuscitation in Children With Cancer With Severe Sepsis / Septic Shock
NCT01304680 ·Status: UNKNOWN
-
Pcrit and TPP for Risk Stratification in Patients with Sepsis
NCT06657196 ·Status: COMPLETED
-
The Predictive Value of Hepatocyte Growth Factor and Soluble Receptor s-Met in Sepsis
NCT03340649 ·Status: UNKNOWN
-
The Efficacy of Xuebijing Injection on Sepsis
NCT03238742 ·Status: COMPLETED ·Phase: PHASE4
-
A Blood Test to Diagnose Sepsis in Symptomatic Adults and Children
NCT05142813 ·Status: UNKNOWN
-
Critical Closing Pressure and PCO₂ Gap in Fluid Resuscitation for Septic Shock
NCT07043192 ·Status: ACTIVE_NOT_RECRUITING
-
Application of Biomarkers Change to Predict Outcome of Patient With Severe Sepsis
NCT02871895 ·Status: UNKNOWN
-
The Impact of Coagulation Disorders on the Diagnosis and Prognosis of Sepsis
NCT05998733 ·Status: UNKNOWN
-
Effect of R-spondin3 on Sepsis Induced Endothelial Dysfunction
NCT04546919 ·Status: UNKNOWN
-
Microcirculatory Guided Goal Directed Fluid Therapy in Septic Shock; a Feasibility Study
NCT03898674 ·Status: UNKNOWN ·Phase: NA
-
Registration of Sepsis Patients in the Emergency Department
NCT06068192 ·Status: NOT_YET_RECRUITING
-
Effect of EGDT on Hepatic Perfusion in Patients With Septic Shock
NCT02060773 ·Status: UNKNOWN
-
The Effect of Rapid Fluid Challenge Under Pulmonary Artery Catheter Monitoring on Physiological Indexes of Patients With Septic Shock
NCT03661268 ·Status: UNKNOWN ·Phase: NA